Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ALC

Alcon (ALC)

Alcon Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ALC
DateTimeSourceHeadlineSymbolCompany
04/07/20245:59PMBusiness WireAlcon Publishes Agenda for 2024 Annual General MeetingNYSE:ALCAlcon Inc
03/12/20244:30AMBusiness WireAlcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in IndiaNYSE:ALCAlcon Inc
03/06/20249:55AMBusiness WireVivity, the World’s Leading EDOF IOL, Reaches One Million MilestoneNYSE:ALCAlcon Inc
03/06/20249:55AMBusiness WireVivity, la LIO à profondeur focale accrue première au monde, atteint un million d’implantsNYSE:ALCAlcon Inc
03/06/20248:00AMBusiness WireVivity, the World’s Leading EDOF IOL, Reaches One Million MilestoneNYSE:ALCAlcon Inc
03/01/20246:44PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
02/29/20245:56PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
02/29/20241:12PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
02/27/20244:30PMBusiness WireAlcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023NYSE:ALCAlcon Inc
02/26/20247:00AMBusiness WireAlgoma Central Corporation Reports Financial Results for Fiscal 2023NYSE:ALCAlcon Inc
02/12/20244:22PMBusiness WireAlgoma Central Corporation to Issue Fiscal 2023 Financial Results on February 26, 2024NYSE:ALCAlcon Inc
02/01/20241:04PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ALCAlcon Inc
02/01/20249:02AMBusiness WireAlcon Canada lance les lentilles cornéennes TOTAL30 Multifocal pour les patients porteurs de lentilles réutilisables atteints de presbytieNYSE:ALCAlcon Inc
01/18/20248:54AMBusiness WireAlgoma Central Corporation continues to grow product tanker business with the acquisition of two additional vesselsNYSE:ALCAlcon Inc
01/10/20244:12AMDow Jones NewsAlcon Shares Rise After Dry-Eye Care Drug Shows Promising ResultsNYSE:ALCAlcon Inc
01/09/20245:20PMDow Jones NewsAlcon Reports Results for Dry-Eye-Treatment TrialsNYSE:ALCAlcon Inc
01/09/20244:30PMBusiness WireAlcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry EyeNYSE:ALCAlcon Inc
01/09/20244:30PMBusiness WireAlcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry EyeNYSE:ALCAlcon Inc
01/05/20248:00AMGlobeNewswire Inc.Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial ArrangementsNYSE:ALCAlcon Inc
12/27/20239:01AMBusiness WireAlcon to Present at 2024 Annual J.P. Morgan Healthcare ConferenceNYSE:ALCAlcon Inc
11/15/202311:08AMDow Jones NewsAlcon Down Over 5%, On Track for Largest Percent Decrease Since May 2022 -- Data TalkNYSE:ALCAlcon Inc
11/15/20236:11AMDow Jones NewsAlcon's Swiss Shares Drop After Guidance Narrowed to Lower End of RangeNYSE:ALCAlcon Inc
11/14/20234:30PMBusiness WireAlcon Reports Third Quarter 2023 ResultsNYSE:ALCAlcon Inc
11/08/20239:03AMBusiness WireAlcon Canada lance Clareon Vivity, sa plus récente avancée en matière de LIO pour la correction de la presbytieNYSE:ALCAlcon Inc
11/03/20233:00PMBusiness WireAlgoma Central Corporation Reports Financial Performance for the 2023 Third QuarterNYSE:ALCAlcon Inc
10/30/20239:01AMBusiness WireAlcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023NYSE:ALCAlcon Inc
10/27/20237:00AMBusiness WireAlgoma Central Corporation to Issue Third Quarter 2023 Financial Results on November 3, 2023NYSE:ALCAlcon Inc
10/10/20238:01AMBusiness WireAlcon Launches TOTAL30 Multifocal Contact Lenses for Patients with PresbyopiaNYSE:ALCAlcon Inc
09/14/20237:00AMBusiness WireAlgoma Central Corporation and Furetank Co-Order Two Additional NewbuildsNYSE:ALCAlcon Inc
09/09/20231:01AMBusiness WireCataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle DependenceNYSE:ALCAlcon Inc
 Showing the most relevant articles for your search:NYSE:ALC